Italy is currently one of the countries most affected by the global emergency of COVID-19, a lethal disease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1 A lot of emergency centers from China,2 United Kingdom, and Italy,3 including our Department of Policlinic Umberto I of Rome, reported a significant number of COVID-19 patients presenting anosmia and ageusia as onset symptoms,4 and it is reported that anosmia appear at an early stage of the disease.

anosmia in COVID-19. Severe acute respiratory syndrome coronavirus 2 through the nasoliary epithelium and a possible spreading way to the central nervous system—a purpose to study / Armocida, Daniele; Pesce, Alessandro; Raponi, Ingrid; Pugliese, Francesco; Valentini, Valentino; Santoro, Antonio; Pugliese, Francesco. - In: NEUROSURGERY. - ISSN 0148-396X. - 87:2(2020), pp. E246-E247. [10.1093/neuros/nyaa204]

anosmia in COVID-19. Severe acute respiratory syndrome coronavirus 2 through the nasoliary epithelium and a possible spreading way to the central nervous system—a purpose to study

Daniele Armocida
Primo
;
Alessandro Pesce
Secondo
;
Ingrid Raponi;Francesco Pugliese;Valentino Valentini;Antonio Santoro
Penultimo
;
Luigi Valentino Berra
Ultimo
2020

Abstract

Italy is currently one of the countries most affected by the global emergency of COVID-19, a lethal disease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1 A lot of emergency centers from China,2 United Kingdom, and Italy,3 including our Department of Policlinic Umberto I of Rome, reported a significant number of COVID-19 patients presenting anosmia and ageusia as onset symptoms,4 and it is reported that anosmia appear at an early stage of the disease.
2020
anosmia; covid-19; severe acute respiratory; severe systemic disease; olfactory dysfunction
01 Pubblicazione su rivista::01f Lettera, Nota
anosmia in COVID-19. Severe acute respiratory syndrome coronavirus 2 through the nasoliary epithelium and a possible spreading way to the central nervous system—a purpose to study / Armocida, Daniele; Pesce, Alessandro; Raponi, Ingrid; Pugliese, Francesco; Valentini, Valentino; Santoro, Antonio; Pugliese, Francesco. - In: NEUROSURGERY. - ISSN 0148-396X. - 87:2(2020), pp. E246-E247. [10.1093/neuros/nyaa204]
File allegati a questo prodotto
File Dimensione Formato  
Armocida_Letter-Anosmia_2020.pdf

accesso aperto

Note: https://academic.oup.com/neurosurgery/article/87/2/E246/5831783; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239107/
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 116.82 kB
Formato Adobe PDF
116.82 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1516177
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 3
social impact